182 related articles for article (PubMed ID: 22152047)
21. Immunization efficacy of cryopreserved genetically attenuated Plasmodium berghei sporozoites.
Prinz H; Sattler JM; Roth A; Ripp J; Adams JH; Frischknecht F
Parasitol Res; 2018 Aug; 117(8):2487-2497. PubMed ID: 29797085
[TBL] [Abstract][Full Text] [Related]
22. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
[TBL] [Abstract][Full Text] [Related]
23. Strain-specific protective effect of the immunity induced by live malarial sporozoites under chloroquine cover.
Wijayalath W; Cheesman S; Tanabe K; Handunnetti S; Carter R; Pathirana S
PLoS One; 2012; 7(9):e45861. PubMed ID: 23029282
[TBL] [Abstract][Full Text] [Related]
24. Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.
Longley RJ; Bauza K; Ewer KJ; Hill AV; Spencer AJ
PLoS One; 2015; 10(3):e0119880. PubMed ID: 25822951
[TBL] [Abstract][Full Text] [Related]
25. Addition of histamine to subcutaneously injected Plasmodium berghei sporozoites increases the parasite liver load and could facilitate whole-parasite vaccination.
Pfeil J; Heine JF; Mueller AK
Malar J; 2015 Jan; 14():36. PubMed ID: 25627880
[TBL] [Abstract][Full Text] [Related]
26. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
[TBL] [Abstract][Full Text] [Related]
27. Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model.
Mizutani M; Fukumoto S; Soubeiga AP; Soga A; Iyori M; Yoshida S
Malar J; 2016 Apr; 15(1):251. PubMed ID: 27129682
[TBL] [Abstract][Full Text] [Related]
28. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
29. Signatures of malaria vaccine efficacy in ageing murine immune memory.
Haussig JM; Burgold J; Hafalla JC; Matuschewski K; Kooij TW
Parasite Immunol; 2014 May; 36(5):199-206. PubMed ID: 24495208
[TBL] [Abstract][Full Text] [Related]
30. CD8+ T cells eliminate liver-stage Plasmodium berghei parasites without detectable bystander effect.
Cockburn IA; Tse SW; Zavala F
Infect Immun; 2014 Apr; 82(4):1460-4. PubMed ID: 24421043
[TBL] [Abstract][Full Text] [Related]
31. Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice.
Purcell LA; Yanow SK; Lee M; Spithill TW; Rodriguez A
Infect Immun; 2008 Mar; 76(3):1193-9. PubMed ID: 18174336
[TBL] [Abstract][Full Text] [Related]
32. Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine.
Mo AX; McGugan G
Am J Trop Med Hyg; 2018 Oct; 99(4):827-832. PubMed ID: 30141395
[TBL] [Abstract][Full Text] [Related]
33. Generating Genetically Modified Plasmodium berghei Sporozoites.
Bowers C; Kurup SP
J Vis Exp; 2023 May; (195):. PubMed ID: 37212590
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium liver load following parenteral sporozoite administration in rodents.
Ploemen IH; Chakravarty S; van Gemert GJ; Annoura T; Khan SM; Janse CJ; Hermsen CC; Hoffman SL; Sauerwein RW
Vaccine; 2013 Jul; 31(34):3410-6. PubMed ID: 23063834
[TBL] [Abstract][Full Text] [Related]
35. An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycle.
De Niz M; Stanway RR; Wacker R; Keller D; Heussler VT
Malar J; 2016 Apr; 15():232. PubMed ID: 27102897
[TBL] [Abstract][Full Text] [Related]
36. Class II-restricted protective immunity induced by malaria sporozoites.
Oliveira GA; Kumar KA; Calvo-Calle JM; Othoro C; Altszuler D; Nussenzweig V; Nardin EH
Infect Immun; 2008 Mar; 76(3):1200-6. PubMed ID: 18160479
[TBL] [Abstract][Full Text] [Related]
37. Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria.
Bijker EM; Nganou-Makamdop K; van Gemert GJ; Zavala F; Cockburn I; Sauerwein RW
Malar J; 2015 Mar; 14():130. PubMed ID: 25889324
[TBL] [Abstract][Full Text] [Related]
38. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.
Sedegah M; Weiss WW; Hoffman SL
Parasite Immunol; 2007 Nov; 29(11):559-65. PubMed ID: 17944745
[TBL] [Abstract][Full Text] [Related]
39. Identification of an AP2-family protein that is critical for malaria liver stage development.
Iwanaga S; Kaneko I; Kato T; Yuda M
PLoS One; 2012; 7(11):e47557. PubMed ID: 23144823
[TBL] [Abstract][Full Text] [Related]
40. Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.
Spaccapelo R; Janse CJ; Caterbi S; Franke-Fayard B; Bonilla JA; Syphard LM; Di Cristina M; Dottorini T; Savarino A; Cassone A; Bistoni F; Waters AP; Dame JB; Crisanti A
Am J Pathol; 2010 Jan; 176(1):205-17. PubMed ID: 20019192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
